Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 854,503 | 921,010 | 998,601 | 1,186,464 | 1,134,644 |
| Cost of Goods | 161,212 | 176,693 | 193,890 | 217,898 | 209,111 |
| Gross Profit | 693,291 | 744,317 | 804,711 | 968,566 | 925,533 |
| Operating Expenses | 627,179 | 651,939 | 697,987 | 799,272 | 749,153 |
| Operating Income | 66,324 | 93,071 | 107,614 | 170,192 | 176,491 |
| Interest Expense | 281 | 262 | 192 | 57 | 507 |
| Other Income | 10,308 | 9,644 | 1,199 | 507 | 1,964 |
| Pre-tax Income | 76,351 | 102,453 | 108,621 | 170,642 | 177,948 |
| Income Tax | 34,291 | 38,665 | 39,271 | 54,137 | 53,284 |
| Net Income Continuous | 42,060 | 63,788 | 69,350 | 116,505 | 124,664 |
| Minority Interests | 30 | N/A | N/A | N/A | N/A |
| Net Income | $42,030 | $63,788 | $69,350 | $116,505 | $124,664 |
| EPS Basic Total Ops | 2.20 | 3.31 | 3.60 | 5.78 | 5.89 |
| EPS Basic Continuous Ops | 2.20 | 3.31 | 3.60 | 5.78 | 5.89 |
| EPS Diluted Total Ops | 2.19 | 3.30 | 3.59 | 5.73 | 5.86 |
| EPS Diluted Continuous Ops | 2.20 | 3.30 | 3.59 | 5.73 | 5.86 |
| EPS Diluted Before Non-Recurring Items | 2.59 | 3.30 | 3.59 | 5.73 | 5.86 |
| EBITDA(a) | $88,553 | $113,466 | $129,024 | $192,385 | $199,000 |